SINGAPORE and SEOUL, Sept. 30, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, and Bukwang Pharmaceutical ...
Bukwang Pharmaceutical recorded an operating profit of 1.6 billion won last year, successfully returning to profitability. This marks a performance improvement after recording its first loss in 2022, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results